The Vanguard Group 13D and 13G filings for Ironwood Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-31 11:44 am Sale |
2024-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
The Vanguard Group | 19,538,555 12.200% |
-2,499,542 (-11.34%) |
Filing |
| 2024-11-12 3:47 pm Unchanged |
2024-09-30 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
The Vanguard Group | 22,038,097 13.790% |
0 (Unchanged) |
Filing |
| 2024-11-04 11:46 am Purchase |
2024-09-30 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
The Vanguard Group | 22,038,097 13.790% |
6,004,552 (+37.45%) |
Filing |
| 2024-01-10 10:16 am Purchase |
2023-12-29 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
The Vanguard Group | 16,033,545 10.270% |
1,300,976 (+8.83%) |
Filing |
| 2023-02-09 11:22 am Purchase |
2022-12-30 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
The Vanguard Group | 14,732,569 9.600% |
1,244,807 (+9.23%) |
Filing |
| 2022-02-10 08:22 am Sale |
2021-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
The Vanguard Group | 13,487,762 8.240% |
-2,404,585 (-15.13%) |
Filing |
| 2021-02-10 11:10 am Sale |
2020-12-31 | 13G | Ironwood Pharmaceuticals, Inc. IRWD |
The Vanguard Group | 15,892,347 9.930% |
-746,594 (-4.49%) |
Filing |